ScalesCD, SmithAC, HanleyJM, SaigalCS. Prevalence of kidney stones in the United States. Eur Urol, 2012; 62:160–165.
2.
LieskeJC, RuleAD, KrambeckAE, et al.Stone composition as a function of age and sex. Clin J Am Soc Nephrol, 2014; 9:2141–2146.
3.
RomeroV, AkpinarH, AssimosDG. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol, 2010; 12:e86–e96.
4.
HarvardTH. Chan School of PublicHealth. Nutrition Department's File DownloadSite. https://regepi.bwh.harvard.edu/health/Oxalate/files Accessed January14, 2021.
5.
AttallaK, DeS, MongaM. Oxalate content of food: A tangled web. Urology, 2014; 84:555–560.
6.
MasseyLK.Food oxalate: Factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc, 2007; 107:1191–1194.
7.
TaylorEN, CurhanGC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol, 2007; 18:2198–2204.
8.
HolmesRP, KennedyM. Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int, 2000; 57:1662–1667.
9.
HolmesRP, GoodmanHO, AssimosDG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int, 2001; 59:270–276.
10.
HolmesRP, GoodmanHO, AssimosDG, SchwillePO, MessaP. Dietary oxalate and its intestinal absorption. Scanning Microsc, 1995; 9:1109–1120.
11.
HolmesRP, AmbrosiusWT, AssimosDG. Dietary oxalate loads and renal oxalate handling. J Urol, 2005; 174:943–947.
12.
ChaiW, LiebmanM, Kynast-GalesS, MasseyL. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis, 2004; 44:1060–1069.
13.
BergslandKJ, ZismanAL, AsplinJR, WorcesterEM, CoeFL. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Ren Physiol, 2011; 300. [Epub ahead of print]; DOI: 10.1152/ajprenal.00411.2010.
14.
CurhanGC, TaylorEN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int, 2008; 73:489–496.
15.
ProchaskaM, TaylorE, FerraroPM, CurhanG. Relative supersaturation of 24-hour urine and likelihood of kidney stones. J Urol, 2018; 199:1262–1266.
16.
BaumannJM.From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis. World J Nephrol, 2014; 3:256.
17.
PakCYC, Adams-HuetB, PoindexterJR, PearleMS, PetersonRD, MoeOW. Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int, 2004; 66:2032–2037.
18.
RodgersA.Aspects of calcium oxalate crystallization: Theory, in vitro studies, and in vivo implementation. J Am Soc Nephrol, 1999; 10(Suppl. 14):S351–S354.
AtkinsGL, DeanBM, GriffinWJ, WattsRW. Quantitative aspects of ascorbic acid metabolism in man. J Biol Chem, 1964; 239:2975–2980.
21.
BakerEM, SaariJC, TolbertBM. Ascorbic acid metabolism in man. Am J Clin Nutr, 1966; 19:371–378.
22.
TaylorEN, CurhanGC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol, 2008; 3:1453–1460.
23.
TaylorEN, StampferMJ, CurhanGC. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow-up. J Am Soc Nephrol, 2004; 15:3225–3232.
24.
ThomasLDK, ElinderCG, TiseliusHG, WolkA, ÅkessonA. Ascorbic acid supplements and kidney stone incidence among men: A prospective study. JAMA Intern Med, 2013; 173:386–388.
25.
KnightJ, AssimosDG, CallahanMF, HolmesRP. Metabolism of primed, constant infusions of [1,2-13C 2] glycine and [1-13C1] phenylalanine to urinary oxalate. Metabolism, 2011; 60:950–956.
26.
FargueS, MillinerDS, KnightJ, OlsonJB, LowtherWT, HolmesRP. Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria. J Am Soc Nephrol, 2018; 29:1615–1623.
27.
RuleAD, KrambeckAE, LieskeJC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol, 2011; 6:2069–2075.
28.
WaikarSS, SrivastavaA, PalssonR, et al.Association of urinary oxalate excretion with the risk of chronic kidney disease progression. JAMA Intern Med, 2019; 179:542–551.
